Product Description
1.Product Name:Ciprofloxacin injection
2.Specification:2% 10ml
3.Packing:10 bottles/box
4.Shelf Life: 36 months
5.Registration documents are available.
If you are interested in our products, please feel free to contact us.
AI Product Description
*The following content is generated by AI and is for reference only.
Ciprofloxacin injection is a sterile, parenteral formulation of ciprofloxacin hydrochloride, a broad-spectrum fluoroquinolone antibiotic widely utilized in clinical settings for treating serious bacterial infections. The chemical entity of the active moiety, ciprofloxacin, possesses the molecular formula C17H18FN3O3 and is identified by the CAS Registry Number 85721-33-1. When formulated as an injectable solution, it typically contains ciprofloxacin base equivalent to the stated concentration, often adjusted with hydrochloric acid to maintain appropriate pH stability and solubility for intravenous administration.
This medication functions by inhibiting bacterial DNA gyrase (topoisomerase II) and topoisomerase IV, essential enzymes required for DNA replication, transcription, repair, and recombination. By interfering with these processes, ciprofloxacin exerts potent bactericidal activity against a diverse array of Gram-negative and Gram-positive organisms. Its spectrum of coverage includes common pathogens such as Escherichia coli, Pseudomonas aeruginosa, Klebsiella species, Staphylococcus aureus, and Proteus mirabilis. Consequently, Ciprofloxacin injection is indicated for the treatment of complicated intra-abdominal infections, pyelonephritis, hospital-acquired pneumonia, skin and soft tissue infections, bone and joint infections, and septicemia caused by susceptible bacteria. It is also frequently employed in cases of anthrax exposure following inhalation.
The intravenous route ensures rapid achievement of therapeutic serum concentrations, making it ideal for patients who cannot tolerate oral medications or require immediate systemic effect. Dosing regimens are generally determined based on infection severity, pathogen susceptibility, renal function, and patient weight. While highly effective, clinicians must remain vigilant regarding potential adverse effects, including tendonitis, tendon rupture, central nervous system disturbances, QT prolongation, and photosensitivity. Additionally, drug interactions with antacids containing magnesium or aluminum can significantly reduce absorption if administered concurrently, though this is less critical in the IV setting compared to oral dosing. As with all antibiotics, prudent use is essential to mitigate the growing threat of antimicrobial resistance. This versatile injectable agent remains a cornerstone therapy in modern infectious disease management, bridging the gap between outpatient oral therapy and more aggressive surgical interventions.